The overexpression of ROS in human nonsmall cell lung cancer cells also promotes CDK1 phosphorylation and suppression of cyclin B1 and CDK1 expression, subsequently blocking CDK1/cyclin B1 complex formation and leading to G2/M phase arrest 104. The gene discussed is CDK1; the disease is lung cancer.